Globus Medical, Inc. (NYSE:GMED) Given Consensus Recommendation of "Moderate Buy" by Analysts dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Globus Medical's (GMED) "Hold" Rating Reaffirmed at Needham & Company LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
BTIG Research Raises Globus Medical (NYSE:GMED) Price Target to $63.00 wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Globus Medical (NYSE:GMED) Price Target Raised to $85.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Globus Medical (NYSE:GMED) Price Target Raised to $85.00 at Barclays dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Paradigm Medical Industries (OTCMKTS:PDMI – Get Rating) and Globus Medical (NYSE:GMED – Get Rating) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Valuation & Earnings This table compares Paradigm Medical Industries […]
Shares of Globus Medical, Inc. (NYSE:GMED – Get Rating) have been assigned a consensus rating of “Buy” from the fourteen ratings firms that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 […]
Globus Medical, Inc. (NYSE:GMED – Get Rating) has been assigned an average recommendation of “Buy” from the fourteen research firms that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1 year price objective among […]